|
시장보고서
상품코드
2045800
소프트 미스트 흡입기 시장 : 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)Soft Mist Inhalers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
세계의 소프트 미스트 흡입기 시장은 2025년에 2억 1,290만 달러로 평가되었고, 2035년까지 연평균 복합 성장률(CAGR) 10.5%를 나타내 5억 6,460만 달러에 이를 것으로 예측됩니다.
시장 확대는 호흡기 질환의 부담 증가, 약물 전달 장치 기술의 지속적인 발전, 흡입 요법에 대한 환자들의 선호도 증가에 의해 주도되고 있습니다. 재택 호흡 관리 솔루션의 도입 확대는 의료 현장 전반에서 그 수요가 더욱 증가하고 있습니다. 천식 및 만성폐쇄성폐질환(COPD)의 유병률 증가와 더불어 기존 정량분무식 흡입기에 비해 폐에 약물 침착이 개선된 점이 시장 성장을 크게 견인할 것으로 예측됩니다. 재택 치료 옵션에 대한 선호도가 높아진 것도 이러한 기기의 보급 확대에 기여하고 있습니다. 소프트미스트 흡입기는 약물을 저속 에어로졸 형태로 폐에 직접 전달하는 효과적인 약물 전달 시스템으로서 치료 효율과 환자 순응도를 향상시키는 데 있어 그중요성이 커지고 있습니다.
| 시장 범위 | |
|---|---|
| 시작 연도 | 2025년 |
| 예측 기간 | 2026-2035년 |
| 시작 연도 시장 규모 | 2억 1,290만 달러 |
| 예측 금액 | 5억 6,460만 달러 |
| CAGR | 10.5% |
성인 부문은 2025년 1억 5,890만 달러 시장 규모를 기록했습니다. 이는 환경오염물질 노출, 직업적 위험, 흡연 등 생활습관 요인에 의한 영향이 커지면서 호흡기 질환에 걸릴 위험이 높아졌기 때문입니다. 천식, 만성폐쇄성폐질환(COPD), 기관지염 등의 질환은 성인에서 더 자주 관찰되며, 그 결과 흡입요법에 대한 의존도가 높아지고 있습니다.
일회용 부문은 에어로졸 전달 기술 및 노즐 엔지니어링의 발전에 힘입어 2025년 64.7%의 점유율을 차지했습니다. 편의성, 감염 예방, 단기 치료 용도에 대한 수요가 증가하면서 보급이 가속화되고 있습니다. 일회용 기기는 유지보수가 필요 없고 교차 오염의 위험을 줄일 수 있어 환자 회전율이 높은 환경이나 자원이 제한된 의료 현장에 적합합니다. 정확한 투약량을 보장하면서도 비용 효율적인 일회용 설계를 위한 지속적인 혁신으로 의료진의 수용도가 더욱 높아지고 있습니다.
2025년 미국의 소프트 미스트 흡입기 시장 규모는 8,780만 달러로 평가되었습니다. 이러한 성장은 소아 및 노인 환자에서의 채택 증가와 더불어 제약회사와 의료기기 제조업체 간의 협력 강화에 힘입은 바 큽니다. 또한, 맞춤형 의료와 표적 치료로의 전환도 수요를 견인하고 있습니다. 소프트미스트 흡입기는 환자 개개인의 요구사항에 따라 정확한 약물 투여를 가능하게 하여 호흡기 치료의 치료 결과를 개선하기 위한 것입니다.
자주 묻는 질문
목차
제1장 조사 방법
제2장 주요 요약
제3장 업계 인사이트
제4장 경쟁 구도
제5장 시장 추산 및 예측 : 제품 유형별(2022-2035년)
제6장 시장 추산 및 예측 : 연령층별(2022-2035년)
제7장 시장 추산 및 예측 : 용도별(2022-2035년)
제8장 시장 추산 및 예측 : 유통 채널별(2022-2035년)
제9장 시장 추산 및 예측 : 최종 용도별(2022-2035년)
제10장 시장 추산 및 예측 : 지역별(2022-2035년)
제11장 기업 개요
KTH 26.06.10The Global Soft Mist Inhalers Market was valued at USD 212.9 million in 2025 and is estimated to grow at a CAGR of 10.5% to reach USD 564.6 million by 2035.
Market expansion is driven by the rising burden of respiratory disorders, continuous advancements in drug delivery device technologies, and increasing patient inclination toward inhalation-based therapies. Growing adoption of home-based respiratory care solutions is further strengthening demand across healthcare settings. The increasing incidence of asthma and chronic obstructive pulmonary disease, along with improved pulmonary drug deposition compared to traditional metered dose inhalers, is expected to significantly support market growth. The expanding preference for at-home treatment options is also contributing to broader adoption of these devices. Soft mist inhalers are gaining importance as effective drug delivery systems that administer medication directly to the lungs in a slow-moving aerosol form, improving therapeutic efficiency and patient compliance.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $212.9 Million |
| Forecast Value | $564.6 Million |
| CAGR | 10.5% |
The adult segment generated USD 158.9 million in 2025, driven by higher exposure to environmental pollutants, occupational risks, and lifestyle factors such as smoking, all of which increase susceptibility to respiratory diseases. Conditions including asthma, chronic obstructive pulmonary disease, and bronchitis are more frequently observed in adults, resulting in greater dependence on inhalation-based therapies.
The disposable segment accounted for 64.7% share in 2025, supported by advancements in aerosol delivery and nozzle engineering. Rising demand for convenience, infection prevention, and short-term treatment applications is accelerating adoption. Disposable devices eliminate maintenance requirements and reduce cross-contamination risks, making them suitable for high-patient-throughput environments and resource-limited healthcare settings. Continuous innovation in cost-efficient disposable designs with accurate dosing has further strengthened their acceptance among healthcare providers.
U.S. Soft Mist Inhalers Market was valued at USD 87.8 million in 2025. Growth is being supported by rising adoption among pediatric and geriatric patients, along with increasing collaborations between pharmaceutical companies and medical device manufacturers. The shift toward personalized medicine and targeted treatment approaches is also driving demand, as soft mist inhalers enable precise drug dosing tailored to individual patient requirements, enhancing therapeutic outcomes in respiratory care.
Key companies operating in the Global Soft Mist Inhalers Market include Boehringer Ingelheim, Aero Pump GmbH, Merxin Ltd., and Changzhou DSB Medical Co. Key strategies adopted by companies in the soft mist inhalers market focus on strengthening drug-device integration through advanced formulation compatibility and precision dosing technologies. Firms are investing heavily in research and development to improve aerosol performance, lung deposition efficiency, and patient usability. Strategic collaborations between pharmaceutical companies and device manufacturers are helping accelerate product innovation and regulatory approvals. Market players are also expanding their geographic presence through partnerships and distribution agreements in emerging healthcare markets. Cost optimization and development of user-friendly disposable and reusable designs are improving accessibility across patient groups.
Table of Contents
Chapter 1 Research Methodology
- 1.1 Research approach
- 1.2 Quality commitments
- 1.2.1 GMI AI policy & data integrity commitment
- 1.2.1.1 Source consistency protocol
- 1.2.1 GMI AI policy & data integrity commitment
- 1.3 Research trail & confidence scoring
- 1.3.1 Research trail components
- 1.3.2 Scoring components
- 1.4 Data collection
- 1.4.1 Partial list of primary sources
- 1.5 Data mining sources
- 1.5.1 Paid sources
- 1.5.1.1 Sources, by region
- 1.5.1 Paid sources
- 1.6 Base estimates and calculations
- 1.6.1 Base year calculation
- 1.7 Forecast model
- 1.7.1 Quantified market impact analysis
- 1.7.1.1 Mathematical impact of growth parameters on forecast
- 1.7.1 Quantified market impact analysis
- 1.8 Research transparency addendum
- 1.8.1 Source attribution framework
- 1.8.2 Quality assurance metrics
- 1.8.3 Our commitment to trust
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
- 2.2 Key market trends
- 2.2.1 Regional trends
- 2.2.2 Product type trends
- 2.2.3 Age group trends
- 2.2.4 Application trends
- 2.2.5 Distribution channel trends
- 2.2.6 End use trends
- 2.3 CXO perspectives: Strategic imperatives
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing prevalence of respiratory conditions
- 3.2.1.2 Surge in patient preference for inhalation therapy
- 3.2.1.3 Technological advancements in devices
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 High cost and availability of alternative products
- 3.2.3 Opportunities
- 3.2.3.1 Expansion into emerging and underpenetrated markets
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape (Driven by Primary Research)
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.4.4 Latin America
- 3.4.5 MEA
- 3.5 Technology and innovation landscape
- 3.5.1 Current technological trends
- 3.5.2 Emerging technologies
- 3.6 Future market trends (Driven by Primary Research)
- 3.7 Soft mist inhaler technology evolution
- 3.8 Impact of AI & generative AI on the market (Driven by Primary Research)
- 3.9 Pricing analysis, 2025 (Driven by Primary Research)
- 3.10 Patent landscape
- 3.11 Gap analysis
- 3.12 Porter's analysis
- 3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2025
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis (Driven by Primary Research)
- 4.3.1 Global
- 4.3.2 North America
- 4.3.3 Europe
- 4.3.4 Asia Pacific
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Key developments
- 4.6.1 Mergers & acquisitions
- 4.6.2 Partnerships & collaborations
- 4.6.3 New product launches
- 4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, By Product Type, 2022 - 2035 ($ Mn)
- 5.1 Key trends
- 5.2 Disposable
- 5.3 Reusable
Chapter 6 Market Estimates and Forecast, By Age Group, 2022 - 2035 ($ Mn)
- 6.1 Key trends
- 6.2 Adult
- 6.3 Pediatric
Chapter 7 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)
- 7.1 Key trends
- 7.2 Asthma
- 7.3 COPD
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2022 - 2035 ($ Mn)
- 8.1 Key trends
- 8.2 Hospital pharmacies
- 8.3 Retail pharmacies
- 8.4 Online pharmacies
Chapter 9 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)
- 9.1 Key trends
- 9.2 Hospitals and clinics
- 9.3 Home care settings
- 9.4 Other end-users
Chapter 10 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)
- 10.1 Key trends
- 10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
- 10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
- 10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
- 10.6 MEA
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE
Chapter 11 Company Profiles
- 11.1 Aero Pump GmbH
- 11.2 Boehringer Ingelheim
- 11.3 Changzhou DSB Medical Co.
- 11.4 Merxin Ltd.
